Copyright
©The Author(s) 2025.
World J Hepatol. Mar 27, 2025; 17(3): 101724
Published online Mar 27, 2025. doi: 10.4254/wjh.v17.i3.101724
Published online Mar 27, 2025. doi: 10.4254/wjh.v17.i3.101724
Figure 3 Effect of Yinchenhao decoction on bile acid active transporters in rats with obstructive jaundice.
A and B: Levels of expression of the cytochrome P450 family 3 subfamily A member 4 (P4503A4), UDP glucuronosyltransferase family 1 member A1 (UGT1A1), multidrug resistance-associated protein (MRP) 3, and 4 in the liver tissue; C and D: Multidrug resistance-associated protein (MRP) 2, and 4 in the kidney tissues; and levels of expression of MRP 2, 4 in the renal tissue. aP < 0.05 vs group S; bP < 0.01 vs Sham (group S); cP < 0.05 vs OJ model (group O); dP < 0.01 vs group O. Group O: Obstructive jaundice model; Group S: Sham; Y group: Yinchenhao decoction-treated.
- Citation: Liu JJ, Mei HW, Jing YY, Li ZL, Wu SG, Yuan HX, Zhang XB. Yinchenhao decoction alleviates obstructive jaundice liver injury by modulating epidermal growth factor receptor and constitutive androstane receptor signaling. World J Hepatol 2025; 17(3): 101724
- URL: https://www.wjgnet.com/1948-5182/full/v17/i3/101724.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i3.101724